Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2025-12-25 @ 12:11 PM
NCT ID:
NCT02891161
Group ID:
EG001
Title:
Arm II: Investigational Treatment Phase II
Description:
Subjects will receive durvalumab 1500mg Q4 weekly with RT to gross disease over 36 fractions. Durvalumab will start on Day 1. RT to start on Day 1 or 2. Subjects will receive adjuvant durvalumab monotherapy Q4 week, up to 12 months. Adjuvant durvalumab monotherapy to start 4 weeks post completion of durvalumab and RT.
durvalumab: 1500 mg Q4 weekly
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
20
Other Number Affected:
20
Other Number At Risk:
20
Study:
NCT02891161
Results Section:
NCT02891161
Adverse Events Module:
NCT02891161